Table II.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Factor | HR (95% CI) | P-value | HR (95% CI) | P-value |
Age (>63 vs. ≤63 years) | 1.433 (1.015–2.023) | 0.041 | 3.895 (1.727–8.783) | 0.001 |
ECOG performance status (0 vs. 1) | 1.709 (1.050–2.781) | 0.006 | 1.120 (0.562–2.233) | 0.697 |
ECOG performance status (0 vs. 2) | 4.137 (0.462–11.707) | 0.007 | 1.913 (0.397–9.206) | 0.419 |
Child-Pugh class (A vs. B) | 1.787 (1.018–3.138) | 0.043 | 0.413 (0.157–1.089) | 0.074 |
BCLC stage (B vs. C) | 1.290 (0.850–1.958) | 0.231 | ||
Basal AFP (≤200 vs. >200 ng/ml) | 1.583 (1.103–2.272) | 0.013 | 2.694 (0.392–5.212) | 0.003 |
AFP reduction [Responders (>20%) vs. Non-responders (≤20)] | 2.032 (1.230–3.357) | 0.006 | 9.723 (2.252–41.969) | 0.002 |
HR, Hazard ratio; CI, confidence interval; AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Disease; ECOG, Eastern Cooperative Oncology Group Performance.